medline.ch Respirationstrakt Neoplasie

	Vebreltinib for Advanced Non-Small Cell Lung Cancer Harboring c-Met Exon 14 Skipping Mutation: A Multicenter, Single-Arm, Phase II KUNPENG Study. J Clin Oncol Yang JJ, Zhang Y, Wu L, Hu J, Wang ZH, Chen JH, Fan Y, Lin G, Wang QM, Yao Y, Zhao J, Chen Y, Fang J, Song Y, Zhang W, Cheng Y, Guo RH, Li XY, Shi HP, Xue WZ, Han D, Zhang PL, Wu YL. PMID: 39058972 [PubMed - as supplied by publisher]
	Pulmonary adenocarcinoma of low malignant potential defines indolent NSCLC associated with overdiagnosis in the national lung screening trial. Cancer Biomark Burks EJ, Sullivan TB, Rieger-Christ KM. PMID: 39058439 [PubMed - as supplied by publisher]
	Biomonitoring Study of Toxic Metal(loid)s: Levels in Lung Adenocarcinoma Patients. Toxics Milo, Milanovi, Sazdani, Sudji J, Jovi, , , Luki, Torovi, Bijelovi, Mili. PMID: 39058142 [PubMed]
	Prediction of the Benign or Malignant Nature of Pulmonary Pure Ground-Glass Nodules Based on Radiomics Analysis of High-Resolution Computed Tomography Images. Tomography Ping X, Jiang N, Meng Q, Hu C. PMID: 39058050 [PubMed - indexed for MEDLINE]
	Automated Lung Cancer Diagnosis Applying Butterworth Filtering, Bi-Level Feature Extraction, and Sparce Convolutional Neural Network to Luna 16 CT Images. J Imaging Gharaibeh NY, De Fazio R, Al-Naami B, Al-Hinnawi AR, Visconti P. PMID: 39057739 [PubMed]
	Confirmation of Recurrent Lung Cancer Following Resection Using Liquid Biopsy, a Proof-of-Concept Real-World Study. Curr Oncol Naso JR, Yip S, Hughesman C, Melosky B, Dowhy T, McConechy MK, English JC, Brasher PMA, Choi J, Grant K, Yee J, Lam S, McGuire A. PMID: 39057174 [PubMed - indexed for MEDLINE]
	Is Spirometry a Sufficient Test for Assessing Respiratory Function after Lung Resection? Curr Oncol Wnuk D, Marja, Tomasik B, , Rzyman W. PMID: 39057167 [PubMed - indexed for MEDLINE]
	A Locally Advanced NSCLC Patient Harboring a Rare KIF13A-RET Fusion Benefited from Pralsetinib: A Case Report. Curr Oncol Chang Z, Zhu T, Jiang H, Ou W, Wang S. PMID: 39057153 [PubMed - indexed for MEDLINE]
	Styrene lung cancer risk assessment: an alternative evaluation of human lung cancer risk assuming mouse lung tumors are potentially human relevant and operating by a threshold-based non-genotoxic mode of action. J Toxicol Environ Health B Crit Rev Bus JS, Su S, Li W, Goodman JE. PMID: 39056307 [PubMed - as supplied by publisher]
	Understanding the treatment response and resistance to targeted therapies in non-small cell lung cancer: clinical insights and perspectives. Front Oncol Zhang H, Zhang Y, Zhu Y, Dong T, Liu Z. PMID: 39055566 [PubMed]
	Systematic review of robotic video-assisted thoracoscopic surgery total pneumonectomy for lung cancer. Kardiochir Torakochirurgia Pol Coco D, Leanza S, Viola MG. PMID: 39055254 [PubMed]
	Pulmonary embolism in cancer patients. Effectiveness of vitamin K antagonists and direct oral anticoagulants in long-term therapy. Kardiochir Torakochirurgia Pol Nadziakiewicz PM, Szygu. PMID: 39055247 [PubMed]
	Site-Specific Cascade-Activatable Fluorogenic Nanomicelles Enable Precision and Accuracy Imaging of Pulmonary Metastatic Tumor. JACS Au Chen X, Liu J, Zhang Y, Gao X, Su D. PMID: 39055141 [PubMed]
	Epacadostat plus pembrolizumab versus placebo plus pembrolizumab as first-line treatment for metastatic non-small cell lung cancer with high levels of programmed death-ligand 1: a randomized, double-blind phase 2 study. BMC Cancer Tokito T, Kolesnik O, Sørensen J, Artac M, Quintela ML, Lee JS, Hussein M, Pless M, Paz-Ares L, Leopold L, Daniel J, Munteanu M, Samkari A, Xu L, Butts C. PMID: 39054476 [PubMed - indexed for MEDLINE]
	Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II study. BMC Cancer Boyer M, Hui R, Urban D, Clingan P, Su WC, Devaux C, Gadgeel S, Garassino M, Leopold L, Daniel J, Munteanu MC, Samkari A, Luo Y, Abreu DR. PMID: 39054462 [PubMed - indexed for MEDLINE]
	A prediction model based on high serum SH2B1 in patients with non-small cell lung cancer. Asian J Surg Lin H, Qiao J, Li L, Zhou Y, Lu L, Zhang C, Cheng Y. PMID: 39054150 [PubMed - as supplied by publisher]
	Safety and efficacy of Immune checkpoint Inhibitors (ICIs) plus chemotherapy versus chemotherapy plus placebo for small cell lung cancer (SCLC): A systematic review and meta-analysis of randomized controlled trials. Asian J Surg Mu X, Wang Y, Fan Z, Yi K. PMID: 39054121 [PubMed - as supplied by publisher]
	Machine learning computational model to predict lung cancer using electronic medical records. Cancer Epidemiol Levi M, Lazebnik T, Kushnir S, Yosef N, Shlomi D. PMID: 39053365 [PubMed - as supplied by publisher]
	Plasma-based near-infrared spectroscopy for early diagnosis of lung cancer. J Pharm Biomed Anal Zhang P, Zhang W, Zhu J, Chen Z, Feng J. PMID: 39053095 [PubMed - as supplied by publisher]
	Meta-analysis of the accuracy for RASSF1A methylation in bronchial aspirates for the diagnosis of lung cancer. PLoS One Chen XP, He SX, Chen MY, Chen FB, Wu P, Shi P, Zhao SC, Zhao LY, Xiong XM, Zeng J. PMID: 39052646 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 141013

Seite 1 von 7051



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung